نتائج البحث 871-880 من 14388 لعملية البحث عن treatment resistant depression
Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia ... treatment. Immunotoxins, such as ...
... treatment monitoring in patients with metastatic breast cancer. I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (I-SPY).
A Study To Evaluate VSV-hIFNbeta-NIS To Treat Patients With Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, Or T-cell Lymphoma. Rochester, Minn., ...
To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...
The purpose of this data registry involves the collection of standard of care clinical treatment regimens, diagnostic information and surgical outcomes which ...
... Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
... treatment with SONALA-001 in combination with ... resistant to platinum drugs. Extracellular Impact ... Testing the Addition of a New Drug, Venetoclax, to the Usual ...
(افتح الدراسات فقط). غربل قائمة الدراسات هذه بالموقع والحالة وغيرها. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.